<DOC>
	<DOCNO>NCT00812838</DOCNO>
	<brief_summary>Peyronie 's disease condition plaque , hard lump , form penis . It cause hardened tissue , pain , abnormal bending penis . These symptom severe erection . Significant bend penis result pain , poor erection , inability engage sexual intercourse . This disease affect 3 % male population . The average age onset disease 57 year old . The cause disease unknown . However , many believe may due trauma penis ( injury extremely vigorous sexual activity ) .</brief_summary>
	<brief_title>H-22411 : BOTOX速 Peyronie 's Disease</brief_title>
	<detailed_description>Treatments disease limit often unsuccessful . The goal treatment reduce pain maintain sexual function . Oral medicine prevent plaque formation promote plaque breakdown effective . Many patient disease require injection medicine directly plaque . These injection use 50 year treatment major Peyronie 's disease . The disease often resolve without treatment . Surgery may perform remove harden tissue penis . However , surgery do first 12 month disease . There 2 phase disease : active phase inactive phase . The active phase usually occur first 12 month disease . The stabilization plaque know inactive phase . We invite men stable disease take part study test BOTOX速 versus placebo ( placebo contain medicine ) . This randomized , placebo-controlled , cross-over , single-center trial . Study drug Botulinum toxin type A ( BOTOX速 ) . Subjects meet inclusion criterion study randomize either treatment placebo arm . - Treatment : Injection solution consist 100 unit BOTOX速 10 cc preservative free normal saline , - Placebo : Injection solution consist 10 cc preservative free normal saline .</detailed_description>
	<mesh_term>Penile Induration</mesh_term>
	<mesh_term>Botulinum Toxins , Type A</mesh_term>
	<mesh_term>incobotulinumtoxinA</mesh_term>
	<mesh_term>abobotulinumtoxinA</mesh_term>
	<mesh_term>onabotulinumtoxinA</mesh_term>
	<mesh_term>Botulinum Toxins</mesh_term>
	<criteria>Subjects stable Peyronie 's plaque . Males least 18 year age Must give informed consent . Subjects active phase Peyronie 's disease . Subjects less 1 year history Peyronie 's disease . Subjects take oral medication Peyronie 's disease include Trentol , Viagra , vitamin E , colchicine , Larginine , tamoxifen . There 2 week washout period patient medication . Subjects 1 penile plaque exclude study . Subjects calcify plaque demonstrate ultrasound exclude study . Known allergy sensitivity component study medication ( botulinum toxin A ) , anesthetic , product associate treatment general study procedure . Any medical condition neuromuscular disorder may put patient increase risk exposure botulinum toxin A ( BTXA ) , include myasthenia gravis , EatonLambert syndrome , amyotrophic lateral sclerosis . Patient take aminoglycosides drug know interfere neuromuscular transmission . Patient hemophilia clot factor deficiency disorder cause bleed diathesis . Patient must take aspirin , nonsteroidal antiinflammatory drug , Coumadin 7 day prior Botox injection . Episode unstable angina pectoris , myocardial infarction , transient ischemic attack , cerebrovascular accident within past 6 month .</criteria>
	<gender>Male</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>November 2016</verification_date>
</DOC>